Rosa Barreira Da Silva

Rosa Barreira Da Silva

Genentech, Inc - South San Francisco / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4428225
-
person_outline Rosa Barreira Da Silva's MOST POPULAR ARTICLES
1-) RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cellsN Yatim, H Jusforgues-Saklani, S Orozco, O Schulz, R Barreira da Silva, ...Science 350 (6258), 328-334, 20154402015
2-) Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyR Barreira da Silva, ME Laird, N Yatim, L Fiette, MA Ingersoll, ML AlbertNature immunology 16 (8), 850-858, 20152402015
3-) Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growthC Hollande, J Boussier, J Ziai, T Nozawa, V Bondet, W Phung, B Lu, ...Nature immunology 20 (3), 257-264, 20191232019
4-) Macroautophagy proteins control MHC class I levels on dendritic cells and shape anti-viral CD8+ T cell responsesM Loi, A Müller, K Steinbach, J Niven, RB da Silva, P Paul, LA Ligeon, ...Cell reports 15 (5), 1076-1087, 20161572016
5-) Human NK cells kill resting but not activated microglia via NKG2D-and NKp46-mediated recognitionA Lünemann, JD Lünemann, S Roberts, B Messmer, RB da Silva, ...The Journal of Immunology 181 (9), 6170-6177, 2008942008